
Stickit Technologies Announces Corporate Update: Leadership Appointments, Capital Restructuring & Loan Acquisition, And Update Of Intellectual Property Portfolio
TheNewswire
Published: Sep 18, 2026, 06:00 AM GMT+9
Sentiment Analysis
Stickit Technologies Announces Corporate Update: Leadership Appointments, Capital Restructuring & Loan Acquisition, And Update Of Intellectual Property Portfolio VANCOUVER, BC September 17, 2026 - TheNewswire — StickIt Technologies Inc. (CSE: STKT) (the "Company" or "StickIt"), a developer and patent holder of proprietary cannabinoid and plant extract delivery technologies, today provides a comprehensive corporate update regarding leadership changes, recent financial transactions including loan acquisitions and private placements, and developments across its international intellectual property portfolio.
CHANGES TO BOARD OF DIRECTORS AND EXECUTIVE MANAGEMENT StickIt is pleased to announce strategic changes to its executive leadership team and Board of Directors designed to accelerate commercial execution and strengthen corporate governance as the Company expands its international presence. Key Governance & Leadership Appointments: • Chief Executive Officer Appointment : Effective July 10, 2026, Dr. Adi Zuloff-Shani has been appointed as Chief Executive Officer succeeding Eli Ben-Haroosh who resigned on April 1, 2026. Dr. Zuloff-Shani brings extensive executive leadership, biotechnology expertise, and operational acumen to drive StickIt's global joint venture strategy and commercial distribution. Dr. Zuloff- Shani is a biomedical executive and immunologist with over two decades of experience leading therapeutic R&D across biotech and pharmaceutical companies. She is the CEO of Clearmind Medicine (NASDAQ: CMND), where she oversees the development of non ‑ hallucinogenic psychedelic ‑ derived treatments for mental ‑ health and addiction disorders. Her career spans drug discovery, CMC, preclinical and clinical development, and global regulatory strategy.
• Board of Directors Additions : Effective July 10, 2026, Mr. Gabriel Kabazo and Mr. Nir Eliyahu have joined the Board of Directors as independent, non-executive directors replacing all previous directors except Mr. Ohad David. Both appointees bring deep financial, capital markets, and corporate governance expertise to the organization. Mr. Kabazo is an experienced finance and operations professional with over 25 years of experience supporting accounting, financing, and IT operations in complex corporate environments. Mr. Kabazo currently serves as Chief Financial Officer or Chief Executive Officer of several public companies listed on the TSX Venture Exchange, Canadian Securities Exchange, and U.S. markets, and brings extensive expertise in public company reporting, financings, and corporate governance. Mr. Eliyahu is a private business owner who specialized in distribution channels and online sales for nine years (2012 to 2021) with Connect Inc. (USA) and Telem distribution in Vancouver. He was responsible for building distribution channels for both B2B and B2C products, brand development, marketing, sales strategies, and a training platform. He has a BSc degree from the University of Ariel in Electrical Engineering.
" We are thrilled to welcome Dr. Adi Zuloff-Shani as our CEO and expand our Board with seasoned independent directors like Mr. Kabazo and Mr. Eliyahu ," stated Ohad David, Chair of the Board. " These appointments mark a critical milestone in sharpening our strategic execution, enhancing board independence, and driving sustainable shareholder value ."
SUMMARY OF RECENT LOAN ACQUISITION & PRIVATE PLACEMENT StickIt has completed key corporate recapitalization and financing milestones to optimize its balance sheet, reduce direct debt obligations, and fund ongoing operational and commercial activities ( See StickIt’s press releases dated October 25 and 29 of 2025;December 31, 2025; and February 17, 2026 ). Debt Restructuring & Loan Acquisition : In connection wit...
Source: TheNewswire
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.